Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

GenStar's new Ad vector for hemophilia A proves safe and effective in murine model

June 13, 2000

AAV-mediated factor IX gene transfer as a therapy for hemophilia B

June 8, 2000

Genentech's single-injection clot buster for heart attack approved by FDA

June 7, 2000

Akzo Nobel's new thrombin inhibitors presented in patent literature

June 6, 2000

Early results from first hemophilia B AAV-mediated gene therapy study

June 6, 2000

Abciximab complements PTCA in patients with AMI

June 6, 2000

Antibodies to von Willebrand factor that act only at sites of thrombus formation

June 2, 2000

PI-88 under development for cardiovascular indication; Progen enters strategic alliance

June 2, 2000

Orally bioavailable thrombin inhibitors designed at Pfizer

June 1, 2000

Antiplatelet effects reported for new cell adhesion inhibitors from Takeda

June 1, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...